Moreover, other studies have found that aging-associated NAD+ deficiency was a critical risk factor for NAFLD, which resulted from NAMPT-controlled NAD+ salvage compromised in liver [22]. Here, NAMPT is linked to metabolic dysfunction-associated steatotic liver disease.